Micromet AG
25Patents
11Active
25Granted
42Portfolio score
Filing activity: Feb 4, 1993 → Oct 27, 2010 · 11 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8236308B2 | Composition comprising cross-species-specific antibodies and uses thereof | Chemistry; Metallurgy | 175 | Active |
| US7112324B1 | CD 19×CD3 specific polypeptides and uses thereof | Chemistry; Metallurgy | 130 | Expired |
| US6723538B2 | Bispecific antibody and chemokine receptor constructs | Chemistry; Metallurgy | 90 | Expired |
| US7635472B2 | Pharmaceutical compositions comprising bispecific anti-cd3, anti-cd19 antibody constructs for the treatment of b-cell related disorders | Chemistry; Metallurgy | 87 | Expired |
| US7235641B2 | Bispecific antibodies | Chemistry; Metallurgy | 77 | Expired |
| US7820166B2 | Potent T cell modulating molecules | Chemistry; Metallurgy | 52 | Expired |
| US8076459B2 | Multispecfic deimmunized CD3-binders | Chemistry; Metallurgy | 49 | Active |
| US6673541B1 | DNA amplification of a single cell | Chemistry; Metallurgy | 49 | Expired |
| US7575923B2 | CD19xCD3 specific polypeptides and uses thereof | Chemistry; Metallurgy | 48 | Expired |
| US7227002B1 | Human antibodies that bind human 17-A1/EpCAM tumor antigen | Chemistry; Metallurgy | 36 | Expired |
| US8101722B2 | Less immunogenic binding molecules | Chemistry; Metallurgy | 35 | Active |
| US7229760B2 | mRNA amplification | Chemistry; Metallurgy | 31 | Expired |
| US8007796B2 | Means and methods for the treatment of tumorous diseases | Chemistry; Metallurgy | 28 | Active |
| US8394926B2 | Pharmaceutical compositions with resistance to soluble CEA | Chemistry; Metallurgy | 18 | Active |
| US8840888B2 | Dosage regimen for administering a CD19XCD3 bispecific antibody | Physics | 17 | Active |
| US7919089B2 | Pharmaceutical composition comprising a bispecific antibody for EpCAM | Emerging Cross-Sectional Technologies | 16 | Expired |
| US8017748B2 | Antibody neutralizers of human granulocyte macrophage colony stimulating factor | Chemistry; Metallurgy | 13 | Active |
| US7435549B1 | Method of identifying binding site domains that retain the capacity of binding to an epitope | Chemistry; Metallurgy | 11 | Expired |
| US7632925B2 | Antibodies that bind human 17-A1/EpCAM tumor antigen | Chemistry; Metallurgy | 10 | Active |
| US8247194B2 | Preparation of scFv antibody fragments | Chemistry; Metallurgy | 4 | Active |
| US7323440B2 | De-immunized MOG (poly)peptide constructs | Emerging Cross-Sectional Technologies | 3 | Expired |
| US7332168B2 | Composition for the elimination of autoreactive B-cells | Emerging Cross-Sectional Technologies | 3 | Expired |
| US7976842B2 | Treatment of metastatic breast cancer | Human Necessities | 2 | Active |
| US7964707B2 | Anti-IL2 antibodies | Chemistry; Metallurgy | 1 | Active |
| US7105638B1 | Product and process for the production, isolation, and purification of recombinant polypeptide | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.